{"id":1627,"date":"2019-03-19T09:23:41","date_gmt":"2019-03-19T08:23:41","guid":{"rendered":"http:\/\/www.nanexa.com\/?p=1627"},"modified":"2019-03-19T09:23:41","modified_gmt":"2019-03-19T08:23:41","slug":"nanexa-erhaller-notice-of-allowance-for-sin-japanska-patentansokan","status":"publish","type":"post","link":"https:\/\/nanexa.com\/sv\/nanexa-erhaller-notice-of-allowance-for-sin-japanska-patentansokan\/","title":{"rendered":"Nanexa erh\u00e5ller \u201dNotice of Allowance\u201d f\u00f6r sin japanska patentans\u00f6kan"},"content":{"rendered":"\r\n<p><strong>Pressmeddelande\u00a0<\/strong><\/p>\r\n\r\n\r\n\r\n<p>Uppsala 2019 03 19<\/p>\r\n\r\n\r\n\r\n<p>&nbsp;<\/p>\r\n\r\n\r\n\r\n<p><strong>Nanexa erh\u00e5ller \u201dNotice of Allowance\u201d f\u00f6r sin japanska patentans\u00f6kan<\/strong><\/p>\r\n\r\n\r\n\r\n<p>Det japanska patentverket har utf\u00e4rdat en s\u00e5 kallad \u201dNotice of Allowance\u201d i Nanexas japanska patentans\u00f6kan r\u00f6rande Bolagets drug delivery-plattform PharmaShell<sup>\u00ae<\/sup>. Notice of Allowance betyder att det japanska patentverket anser att patentans\u00f6kan uppfyller de krav som kan st\u00e4llas f\u00f6r att erh\u00e5lla ett godk\u00e4nnande. Det g\u00e5r dock i dagsl\u00e4get inte s\u00e4ga n\u00e5got om n\u00e4r patent kommer beviljas d\u00e5 processen fortfarande p\u00e5g\u00e5r.\u00a0<\/p>\r\n\r\n\r\n\r\n<p>&nbsp;<\/p>\r\n\r\n\r\n\r\n<p><em>Nanexas VD David Westberg kommenterar:<\/em><\/p>\r\n\r\n\r\n\r\n<p><em>Vi ser det japanska patentverkets tillk\u00e4nnagivande g\u00e4llande patenterbarheten hos Nanexas teknologi som n\u00e5got v\u00e4ldigt positivt. Den japanska marknaden \u00e4r viktig f\u00f6r l\u00e4kemedelsbranschen och ett godk\u00e4nt patent st\u00e4rker oss i v\u00e5r position n\u00e4r vi samtalar med nuvarande och framtida partners.<\/em><\/p>\r\n\r\n\r\n\r\n<p>F\u00f6r mer information kontakta:<\/p>\r\n\r\n\r\n\r\n<p>David Westberg \u2013 VD, Nanexa AB (publ)\u00a0<\/p>\r\n\r\n\r\n\r\n<p>\u2028Telefon: 0709 &#8211; 42 83 03\u2028<\/p>\r\n\r\n\r\n\r\n<p>E-post:\u00a0<a href=\"mailto:david.westberg@nanexa.se\">david.westberg@nanexa.se<\/a><\/p>\r\n\r\n\r\n\r\n<p><a href=\"http:\/\/www.nanexa.com\/\">www.nanexa.com<\/a><\/p>\r\n\r\n\r\n\r\n<p>Om Nanexa AB (publ)<\/p>\r\n\r\n\r\n\r\n<p>Nanexa AB \u00e4r ett nanoteknologiskt drug delivery-f\u00f6retag som fokuserar verksamheten p\u00e5 utvecklingen av PharmaShell<sup>\u00ae<\/sup>som \u00e4r ett nytt och banbrytande drug delivery-system som bed\u00f6ms ha en stor potential inom ett flertal indikationsomr\u00e5den. Inom ramen f\u00f6r PharmaShell<sup>\u00ae<\/sup>har Nanexa samarbetsavtal med bland andra AstraZeneca.<\/p>\r\n","protected":false},"excerpt":{"rendered":"<p>Pressmeddelande\u00a0<\/p>\n<p>Uppsala 2019 03 19<\/p>\n<p>&nbsp;<\/p>\n<p>Nanexa erh\u00e5ller \u201dNotice of Allowance\u201d f\u00f6r sin japanska patentans\u00f6kan<\/p>\n<p>Det japanska patentverket har utf\u00e4rdat en s\u00e5 kallad \u201dNotice of Allowance\u201d i Nanexas japanska patentans\u00f6kan r\u00f6rande Bolagets drug delivery-plattform PharmaShell\u00ae.<\/p>\n<p><a class=\"read-more\" href=\"https:\/\/nanexa.com\/sv\/nanexa-erhaller-notice-of-allowance-for-sin-japanska-patentansokan\/\">L\u00e4s mer<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[13],"tags":[],"class_list":["post-1627","post","type-post","status-publish","format-standard","hentry","category-pressmeddelanden"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanexa erh\u00e5ller \u201dNotice of Allowance\u201d f\u00f6r sin japanska patentans\u00f6kan - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/nanexa-erhaller-notice-of-allowance-for-sin-japanska-patentansokan\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexa erh\u00e5ller \u201dNotice of Allowance\u201d f\u00f6r sin japanska patentans\u00f6kan - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Pressmeddelande\u00a0    Uppsala 2019 03 19    &nbsp;    Nanexa erh\u00e5ller \u201dNotice of Allowance\u201d f\u00f6r sin japanska patentans\u00f6kan    Det japanska patentverket har utf\u00e4rdat en s\u00e5 kallad \u201dNotice of Allowance\u201d i Nanexas japanska patentans\u00f6kan r\u00f6rande Bolagets drug delivery-plattform PharmaShell\u00ae.L\u00e4s mer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/nanexa-erhaller-notice-of-allowance-for-sin-japanska-patentansokan\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta property=\"article:published_time\" content=\"2019-03-19T08:23:41+00:00\" \/>\n<meta name=\"author\" content=\"Anders Johansson\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skriven av\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anders Johansson\" \/>\n\t<meta name=\"twitter:label2\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-erhaller-notice-of-allowance-for-sin-japanska-patentansokan\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-erhaller-notice-of-allowance-for-sin-japanska-patentansokan\\\/\"},\"author\":{\"name\":\"Anders Johansson\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/person\\\/d26735c022a71d41737953c23a07692a\"},\"headline\":\"Nanexa erh\u00e5ller \u201dNotice of Allowance\u201d f\u00f6r sin japanska patentans\u00f6kan\",\"datePublished\":\"2019-03-19T08:23:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-erhaller-notice-of-allowance-for-sin-japanska-patentansokan\\\/\"},\"wordCount\":228,\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"articleSection\":[\"Pressmeddelanden\"],\"inLanguage\":\"sv-SE\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-erhaller-notice-of-allowance-for-sin-japanska-patentansokan\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/nanexa-erhaller-notice-of-allowance-for-sin-japanska-patentansokan\\\/\",\"name\":\"Nanexa erh\u00e5ller \u201dNotice of Allowance\u201d f\u00f6r sin japanska patentans\u00f6kan - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2019-03-19T08:23:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-erhaller-notice-of-allowance-for-sin-japanska-patentansokan\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/nanexa-erhaller-notice-of-allowance-for-sin-japanska-patentansokan\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-erhaller-notice-of-allowance-for-sin-japanska-patentansokan\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanexa erh\u00e5ller \u201dNotice of Allowance\u201d f\u00f6r sin japanska patentans\u00f6kan\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/person\\\/d26735c022a71d41737953c23a07692a\",\"name\":\"Anders Johansson\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g\",\"caption\":\"Anders Johansson\"},\"url\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/author\\\/anders\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexa erh\u00e5ller \u201dNotice of Allowance\u201d f\u00f6r sin japanska patentans\u00f6kan - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/nanexa-erhaller-notice-of-allowance-for-sin-japanska-patentansokan\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexa erh\u00e5ller \u201dNotice of Allowance\u201d f\u00f6r sin japanska patentans\u00f6kan - Nanexa AB","og_description":"Pressmeddelande\u00a0    Uppsala 2019 03 19    &nbsp;    Nanexa erh\u00e5ller \u201dNotice of Allowance\u201d f\u00f6r sin japanska patentans\u00f6kan    Det japanska patentverket har utf\u00e4rdat en s\u00e5 kallad \u201dNotice of Allowance\u201d i Nanexas japanska patentans\u00f6kan r\u00f6rande Bolagets drug delivery-plattform PharmaShell\u00ae.L\u00e4s mer","og_url":"https:\/\/nanexa.com\/nanexa-erhaller-notice-of-allowance-for-sin-japanska-patentansokan\/","og_site_name":"Nanexa AB","article_published_time":"2019-03-19T08:23:41+00:00","author":"Anders Johansson","twitter_card":"summary_large_image","twitter_misc":{"Skriven av":"Anders Johansson","Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanexa.com\/nanexa-erhaller-notice-of-allowance-for-sin-japanska-patentansokan\/#article","isPartOf":{"@id":"https:\/\/nanexa.com\/nanexa-erhaller-notice-of-allowance-for-sin-japanska-patentansokan\/"},"author":{"name":"Anders Johansson","@id":"https:\/\/nanexa.com\/#\/schema\/person\/d26735c022a71d41737953c23a07692a"},"headline":"Nanexa erh\u00e5ller \u201dNotice of Allowance\u201d f\u00f6r sin japanska patentans\u00f6kan","datePublished":"2019-03-19T08:23:41+00:00","mainEntityOfPage":{"@id":"https:\/\/nanexa.com\/nanexa-erhaller-notice-of-allowance-for-sin-japanska-patentansokan\/"},"wordCount":228,"publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"articleSection":["Pressmeddelanden"],"inLanguage":"sv-SE"},{"@type":"WebPage","@id":"https:\/\/nanexa.com\/nanexa-erhaller-notice-of-allowance-for-sin-japanska-patentansokan\/","url":"https:\/\/nanexa.com\/nanexa-erhaller-notice-of-allowance-for-sin-japanska-patentansokan\/","name":"Nanexa erh\u00e5ller \u201dNotice of Allowance\u201d f\u00f6r sin japanska patentans\u00f6kan - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2019-03-19T08:23:41+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/nanexa-erhaller-notice-of-allowance-for-sin-japanska-patentansokan\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/nanexa-erhaller-notice-of-allowance-for-sin-japanska-patentansokan\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/nanexa-erhaller-notice-of-allowance-for-sin-japanska-patentansokan\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"Nanexa erh\u00e5ller \u201dNotice of Allowance\u201d f\u00f6r sin japanska patentans\u00f6kan"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nanexa.com\/#\/schema\/person\/d26735c022a71d41737953c23a07692a","name":"Anders Johansson","image":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/secure.gravatar.com\/avatar\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g","caption":"Anders Johansson"},"url":"https:\/\/nanexa.com\/sv\/author\/anders\/"}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/1627","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/comments?post=1627"}],"version-history":[{"count":3,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/1627\/revisions"}],"predecessor-version":[{"id":1630,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/1627\/revisions\/1630"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=1627"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/categories?post=1627"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/tags?post=1627"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}